GlaxoSmithKline Recalls Weight-Loss Drug Alli In U.S. After Tampering

Some bottles of Alli, GlaxoSmithKline Plc's weight-loss drug sold over the counter in the United States, have been tampered with, and the Food and Drug Administration was investigating, the company said on Wednesday. Consumers have reported that about 20 bottles bought in stores in seven mostly Southern states contained products other than the drug, GlaxoSmithKline said. The company said the affected bottles from five lots of the drug could contain tablets and capsules of different shapes and colors.

Help employers find you! Check out all the jobs and post your resume.